Literature DB >> 3439808

Pharmacokinetics of the acyclureidopenicillins piperacillin and mezlocillin in the postpartum patient.

M G Martens1, S Faro, S Feldman, D B Cotton, K Dorman, G D Riddle.   

Abstract

The postpartum patient experiences numerous physiologic alterations, which may affect the pharmacokinetics of certain drugs. Six patients received either piperacillin or mezlocillin intravenously immediately after delivery. Serum half-life and clearance were, respectively, 82.4 min and 202 +/- 105 ml/min for mezlocillin and 32.9 min and 456 +/- 88 ml/min for piperacillin. The data revealed that mezlocillin and piperacillin have significantly different pharmacokinetic reactions in the postpartum patient at the doses used.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3439808      PMCID: PMC175848          DOI: 10.1128/AAC.31.12.2015

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  Pharmacokinetics of cefoperazone in the parturient.

Authors:  B Gonik; S Feldman; L K Pickering; C G Doughtie
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

2.  Comparative pharmacokinetics of low- and high-dose ticarcillin.

Authors:  B J Guglielmo; J F Flaherty; R Batman; S L Barriere; J G Gambertoglio
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

Review 3.  Review of the pharmacokinetics of mezlocillin.

Authors:  T Bergan
Journal:  J Antimicrob Chemother       Date:  1983-05       Impact factor: 5.790

4.  Drug disposition and pharmacokinetics in the maternal-placental-fetal unit.

Authors:  B Krauer; F Krauer; F E Hytten
Journal:  Pharmacol Ther       Date:  1980       Impact factor: 12.310

5.  Ampicillin kinetics in pregnancy.

Authors:  B M Assael; M L Como; M Miraglia; G Pardi; F Sereni
Journal:  Br J Clin Pharmacol       Date:  1979-09       Impact factor: 4.335

6.  Pharmacokinetics of piperacillin in the postpartum patient.

Authors:  D Charles; B Larsen
Journal:  Gynecol Obstet Invest       Date:  1985       Impact factor: 2.031

7.  Comparative pharmacokinetics of two multiple-dose mezlocillin regimens in normal volunteers.

Authors:  P A Colaizzi; A A Coniglio; W J Poynor; N Vishniavsky; H T Karnes; R E Polk
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

8.  Mezlocillin pharmacokinetics after single intravenous doses to patients with varying degrees of renal function.

Authors:  N Frimodt-Möller; S Maigaard; R D Toothaker; R W Bundtzen; M V Brodey; W A Craig; P G Welling; P O Madsen
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

9.  Pharmacokinetics of cefotaxime in the postpartum patient.

Authors:  B Gonik; D B Cotton; S Feldman; T G Cleary; L K Pickering
Journal:  Am J Perinatol       Date:  1985-04       Impact factor: 1.862

Review 10.  Overview of acylureidopenicillin pharmacokinetics.

Authors:  T Bergan
Journal:  Scand J Infect Dis Suppl       Date:  1981
View more
  2 in total

Review 1.  Pharmacokinetic changes during pregnancy and their clinical relevance.

Authors:  R Loebstein; A Lalkin; G Koren
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

Review 2.  Review of beta-lactam antibiotics in pregnancy. The need for adjustment of dosage schedules.

Authors:  A Heikkilä; R Erkkola
Journal:  Clin Pharmacokinet       Date:  1994-07       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.